Alira Health Ventures portfolio company, X-COR Therapeutics, closes initial $2.6M funding round X-COR’s innovative technology transforms support [...]

Go behind the scenes to see how the Alira Health team analyzed the unmet needs, understood and mapped the competitive landscape, and identified [...]

How will the new WHO recommendations on pharmaceutical pricing policies affect your organization? The WHO recently launched a series of [...]

We are proud to announce our role as strategic advisor to Benvic in the acquisition of Luc & Bel. Benvic is a French group leader in the [...]